Literature DB >> 29402738

Potentiation of the activity of β-lactam antibiotics by farnesol and its derivatives.

Choon Kim1, Dusan Hesek1, Mijoon Lee1, Shahriar Mobashery2.   

Abstract

Farnesol, a sesquiterpene alcohol, potentiates the activity of β-lactam antibiotics against antibiotic-resistant bacteria. We document that farnesol and two synthetic derivatives (compounds 2 and 6) have poor antibacterial activities of their own, but they potentiate the activities of ampicillin and oxacillin against Staphylococcus aureus strains (including methicillin-resistant S. aureus). These compounds attenuate the rate of growth of bacteria, which has to be taken into account in assessment of the potentiation effect.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial activity; Farnesol; Methicillin-resistant Staphylococcus aureus (MRSA); Potentiation; β-Lactam antibiotics

Mesh:

Substances:

Year:  2018        PMID: 29402738      PMCID: PMC5817034          DOI: 10.1016/j.bmcl.2018.01.028

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  Synergy, antagonism, and what the chequerboard puts between them.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

2.  The antibacterial effects of terpene alcohols on Staphylococcus aureus and their mode of action.

Authors:  Yoshihiro Inoue; Akiko Shiraishi; Toshiko Hada; Kazuma Hirose; Hajime Hamashima; Jingoro Shimada
Journal:  FEMS Microbiol Lett       Date:  2004-08-15       Impact factor: 2.742

3.  Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance.

Authors:  Mary Ann Jabra-Rizk; Mark Shirtliff; Cathy James; Timothy Meiller
Journal:  FEMS Yeast Res       Date:  2006-11       Impact factor: 2.796

4.  Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin-resistant Staphylococcus aureus.

Authors:  Makoto Kuroda; Sanae Nagasaki; Toshiko Ohta
Journal:  J Antimicrob Chemother       Date:  2007-01-22       Impact factor: 5.790

5.  Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility.

Authors:  M A Jabra-Rizk; T F Meiller; C E James; M E Shirtliff
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

6.  The fractional inhibitory concentration (FIC) index as a measure of synergy.

Authors:  M J Hall; R F Middleton; D Westmacott
Journal:  J Antimicrob Chemother       Date:  1983-05       Impact factor: 5.790

7.  Farnesol-Induced Disruption of the Staphylococcus aureus Cytoplasmic Membrane.

Authors:  Yoshihiro Inoue; Naoko Togashi; Hajime Hamashima
Journal:  Biol Pharm Bull       Date:  2016       Impact factor: 2.233

8.  Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia pseudomallei.

Authors:  R S N Brilhante; L G A Valente; M F G Rocha; T J P G Bandeira; R A Cordeiro; R A C Lima; J J G Leite; J F Ribeiro; J F Pereira; D S C M Castelo-Branco; A J Monteiro; J J C Sidrim
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

9.  Effect of farnesol on mevalonate pathway of Staphylococcus aureus.

Authors:  Mizuho Kaneko; Naoko Togashi; Hajime Hamashima; Masayoshi Hirohara; Yoshihiro Inoue
Journal:  J Antibiot (Tokyo)       Date:  2011-07-20       Impact factor: 2.649

10.  Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents.

Authors:  P F Dougherty; D W Yotter; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

View more
  1 in total

Review 1.  The Revaluation of Plant-Derived Terpenes to Fight Antibiotic-Resistant Infections.

Authors:  Floriana Cappiello; Maria Rosa Loffredo; Cristina Del Plato; Silvia Cammarone; Bruno Casciaro; Deborah Quaglio; Maria Luisa Mangoni; Bruno Botta; Francesca Ghirga
Journal:  Antibiotics (Basel)       Date:  2020-06-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.